<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35032963</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1868-8551</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>ALTEX</Title><ISOAbbreviation>ALTEX</ISOAbbreviation></Journal><ArticleTitle>COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.</ArticleTitle><Pagination><StartPage>322&#x2013;335</StartPage><MedlinePgn>322&#x2013;335</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14573/altex.2112161</ELocationID><Abstract><AbstractText>On April 28-29, 2021, 50 scientists from different fields of expertise met for the 3rd online CIAO workshop. The CIAO project &#x201c;Modelling the Pathogenesis of COVID-19 using the Adverse Outcome Pathway (AOP) framework&#x201d; aims at building a holistic assembly of the available scientific knowledge on COVID-19 using the AOP framework. An individual AOP depicts the disease progression from the initial contact with the SARS-CoV-2 virus through biological key events (KE) toward an adverse outcome such as respiratory distress, anosmia or multiorgan failure. Assembling the individual AOPs into a network highlights shared KEs as central biological nodes involved in multiple outcomes observed in COVID-19 patients. During the workshop, the KEs and AOPs established so far by the CIAO members were presented and posi&#xad;tioned on a timeline of the disease course. Modulating factors influencing the progression and severity of the disease were also addressed as well as factors beyond purely biological phenomena. CIAO relies on an interdisciplinary crowd&#xad;sourcing effort, therefore, approaches to expand the CIAO network by widening the crowd and reaching stakeholders were also discussed. To conclude the workshop, it was decided that the AOPs/KEs will be further consolidated, inte&#xad;grating virus variants and long COVID when relevant, while an outreach campaign will be launched to broaden the CIAO scientific crowd.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clerbaux</LastName><ForeName>Laure-Alix</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amig&#xf3;</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Biosfer Teslab, Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Maria Jo&#xe3;o</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Instituto Gulbenkian de Ci&#xea;ncia, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bal-Price</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batista Leite</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beronius</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bezemer</LastName><ForeName>Gillina F G</ForeName><Initials>GFG</Initials><AffiliationInfo><Affiliation>Impact Station, Hilversum, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bostroem</LastName><ForeName>Ann-Charlotte</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carusi</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Interchange Research, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coecke</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Concha</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fairleigh Dickinson University, Green Neuroscience Laboratory, San Diego, CA, USA</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daskalopoulos</LastName><ForeName>Evangelos P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bernardi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Otorhinolaryngology, Department of Biotechnologies and Life Sciences, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edrosa</LastName><ForeName>Eizleayne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Steve W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>RTI International, Research Triangle Park, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipovska</LastName><ForeName>Julija</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Independent scientist, Ohrid, North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Reyero</LastName><ForeName>Nat&#xe0;lia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>US Army Engineer Research and Development Center, Vicksburg, MS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavins</LastName><ForeName>Felicity N E</ForeName><Initials>FNE</Initials><AffiliationInfo><Affiliation>The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halappanavar</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Alan J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>School of Science and Technology, Nottingham Trent University, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogberg</LastName><ForeName>Helena T</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh</LastName><ForeName>Myl&#xe8;ne T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biosciences, Oak Ridge National Laboratory, Oak Ridge, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Josephs-Spaulding</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Experimental Medicine, Kiel University, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young Jun</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbr&#xfc;cken, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Hyun Joon</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>University of Illinois at Urbana-Champaign, Champaign, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krebs</LastName><ForeName>Catharine E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Physicians Committee for Responsible Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landesmann</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Layton</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>US Consumer Product Safety Commission, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yong Oh</ForeName><Initials>YO</Initials><AffiliationInfo><Affiliation>Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbr&#xfc;cken, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macmillan</LastName><ForeName>Donna S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Humane Society International, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto Superiore di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margiotta-Casaluci</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Marvin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masereeuw</LastName><ForeName>Rosalinde</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayasich</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison Aquatic Sciences Center at US EPA, Duluth, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Liang Merlin</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>US EPA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortensen</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>US EPA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz Pineiro</LastName><ForeName>Amalia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Geel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nymark</LastName><ForeName>Penny</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohayon</LastName><ForeName>Elan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojasi</LastName><ForeName>Joshi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hiranandani College of Pharmacy, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paini</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parissis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parvatam</LastName><ForeName>Surat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Predictive Human Model Systems Atal Incubation Centre - Centre for Cellular and Molecular Biology Habsiguda, Hyderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistollato</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy. Francesca.PISTOLLATO@ec.europa.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachana</LastName><ForeName>Magdalini</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Environment Health and Safety Division, Environment Directorate, Organisation for Economic Cooperation and Development (OECD), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rli</LastName><ForeName>Jorid Birkelund</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>The National Research Centre for the Working Environment, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Kristie M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Physicians Committee for Responsible Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sund</LastName><ForeName>Jukka</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanabe</LastName><ForeName>Shihori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsaioun</LastName><ForeName>Katya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinken</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viviani</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Humane Society International, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waspe</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willett</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Humane Society International, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittwehr</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EPA999999</GrantID><Acronym>ImEPA</Acronym><Agency>Intramural EPA</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG053303</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>ALTEX</MedlineTA><NlmUniqueID>100953980</NlmUniqueID><ISSNLinking>1868-596X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073931" MajorTopicYN="Y">Adverse Outcome Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adverse outcome pathway</Keyword><Keyword MajorTopicYN="N">interdisciplinarity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>20</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35032963</ArticleId><ArticleId IdType="mid">NIHMS1867515</ArticleId><ArticleId IdType="pmc">PMC10069302</ArticleId><ArticleId IdType="doi">10.14573/altex.2112161</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bezemer GFG, Garssen J. (2021). TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target. Front Pharmacol 11, 1&#x2013;17. doi:10.3389/fphar.2020.601685</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.601685</ArticleId><ArticleId IdType="pmc">PMC7844586</ArticleId><ArticleId IdType="pubmed">33519463</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne AW, McEvoy D, Collins AB et al. (2020). Inferred duration of infectious period of SARS-CoV-2: Rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open 10, 1&#x2013;16. doi:10.1136/bmjopen-2020-039856</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039856</ArticleId><ArticleId IdType="pmc">PMC7409948</ArticleId><ArticleId IdType="pubmed">32759252</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT (2020). A Proposed Framework and Timeline ofthe Spectrum of Disease Due to SARS-CoV-2 Infection Illness Beyond Acute Infection and Public Health Implications. JAMA 324, 2251&#x2013;2252. doi:10.1093/cid/ciaa1280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1280</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Park C, Lim S. et al. (2021). Advanced Adverse Outcome Pathways Potentially Bridging Pathogenesis of COVID-19. Preprints 2021010065. doi:10.20944/preprints202101.0065.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202101.0065.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinaret PAS, del Giudice G, Dario G. (2020). Covid-19 acute responses and possible long term consequences: What nanotoxicology can teach us. Nano Today 35. doi:10.1016/j.nantod.2020.100945</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nantod.2020.100945</ArticleId><ArticleId IdType="pmc">PMC7416770</ArticleId><ArticleId IdType="pubmed">32834832</ArticleId></ArticleIdList></Reference><Reference><Citation>Nymark P, Sachana M, Leite SB et al. (2021). Systematic organization of COVID-19 data supported by the Adverse Outcome Pathway framework. Preprints doi:10.20944/preprints202101.0573.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202101.0573.v1</ArticleId><ArticleId IdType="pmc">PMC8170012</ArticleId><ArticleId IdType="pubmed">34095051</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak SB, Van Gool IC, Cohen D. et al. (2020). A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 33, 2128&#x2013;2138. doi:10.1038/s41379-020-0603-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0603-3</ArticleId><ArticleId IdType="pmc">PMC7306927</ArticleId><ArticleId IdType="pubmed">32572155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai B, Shukla A, Dwivedi LK (2021). Estimates of serial interval for COVID-19: A systematic review and meta- analysis. Clin Epidemiol Glob Healh 9, 157&#x2013;161. doi:10.1186/s12879-021-05950-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05950-x</ArticleId><ArticleId IdType="pmc">PMC7448781</ArticleId><ArticleId IdType="pubmed">32869006</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve DL, Crump D, Garcia-Reyero N. et al. (2014). Adverse outcome pathway (AOP) development I: Strategies and principles. Toxicol Sci 142, 312&#x2013;320. doi:10.1093/toxsci/kfu199</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfu199</ArticleId><ArticleId IdType="pmc">PMC4318923</ArticleId><ArticleId IdType="pubmed">25466378</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve DL, Landesmann B, Allavena P. et al. (2019). Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways. Adv Ecol Res 60, 1&#x2013;24. doi:10.1093/toxsci/kfy047.Submit</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfy047.Submit</ArticleId><ArticleId IdType="pmc">PMC6309953</ArticleId><ArticleId IdType="pubmed">29850905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinken M. (2013). The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 312, 158&#x2013;165. doi:10.1016/j.tox.2013.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2013.08.011</ArticleId><ArticleId IdType="pubmed">23978457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Qu M, Zhou X. et al. (2020). The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China. J Transl Med 18, 1&#x2013;11. doi:10.1186/s12967-020-02423-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02423-8</ArticleId><ArticleId IdType="pmc">PMC7332535</ArticleId><ArticleId IdType="pubmed">32620125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittwehr C, Amorim MJ, Clerbaux L-A et al. (2021). Understanding COVID-19 through adverse outcome pathways &#x2013; 2nd CIAO AOP Design Workshop. ALTEX 38, 351&#x2013;357. doi:10.14573/altex.2102221</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2102221</ArticleId><ArticleId IdType="pubmed">33677612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>